Cadila Healthcare informs about analyst meet

12 May 2021 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cadila Healthcare has informed that a call of the analysts and investors with the management is scheduled today evening i.e. May 12, 2021 between 4:30 pm to 5:00 pm to discuss about the transaction, which was announced earlier today ‘Zydus Cadila entity to sell its India focused Animal Health Business to Multiples Alternate Asset Management led consortium’. Dr. Sharvil Patel, Managing Director, Cadila Healthcare would be hosting the call. The dial-in details of the conference call are enclosed.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

937.80 2.80 (0.30%)
16-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1536.95
Dr. Reddys Lab 6038.00
Cipla 1384.30
Zydus Lifesciences 937.80
Lupin 1613.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.